Navigating DOJ Enforcement in Healthcare & Private Equity

As private equity’s role in healthcare has increased dramatically over the last few years, so has DOJ’s scrutiny over PE investors. DOJ recently announced a task force on Health Care Monopolies and Collusion dedicated to investigating competition in healthcare. The Department is also increasingly pursuing private equity investors for alleged False Claims Act and corporate criminal violations committed by their portfolio companies and recent cases have tested novel theories of FCA liability. The number of qui tam suits and government enforcement actions targeting private equity firms has grown significantly as well.

Join us on September 12 as we explore the latest civil and criminal enforcement landscape surrounding PE ownership in healthcare.